Drugs: the complete collection

SnortingEffectiveness bank home page. Opens new window Collection
Drugs: the complete collection

All Effectiveness Bank analyses to date of documents related to use and problem use of illegal drugs starting with the analyses most recently added or updated, totalling today 746 documents.

Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents



STUDY 2015 HTM file
Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial

D’Onofrio G., O’Connor P.G., Pantalon M.V. et al.
JAMA: 2015, 313(16), p. 1636–1644.
Please come back again soon. This entry is under construction.

MATRIX CELL 2018 HTM file
Drug Treatment Matrix cell D5: Organisational functioning; Safeguarding the community

Ashton M.
Key research on the influence of the treatment organisation on the effectiveness of drug treatment in the criminal justice system and allied settings. Asks whether the criminal justice context enhances or limits treatment (perhaps both), whether quality is better in smaller services, and whether treatment services should see themselves as family services.

STUDY 2012 HTM file
Adaptive programming improves outcomes in drug court: an experimental trial

Marlowe D.B., Festinger D.S., Dugosh K.L. et al.
Criminal Justice and Behavior: 2012, 39(4), p. 514–532.
Latest in an impressively coherent and persistent series of studies of how US courts specialising in supervision and treatment of drug-related offenders can do more to reduce drug use and crime. Triaging offenders to more or less intensive programmes and then adjusting based on actual progress made significant differences.

MATRIX CELL 2018 HTM file
Drug Treatment Matrix cell C5: Management/supervision: Safeguarding the community

Ashton M.
Key studies on the influence of management and supervision on treatment’s impacts on crime and safeguarding the community, with a focus on criminal justice and child protection contexts. Examine the credentials of the most well known model for working with offenders, ask yourself why cognitive-behavioural approaches are so prominent, and explore the feasibility of focusing on the child when the parent is the patient.

DOCUMENT 2018 HTM file
Medications for opioid use disorder: for healthcare and addiction professionals, policymakers, patients, and families: Treatment Improvement Protocol: TIP 63

Substance Abuse and Mental Health Services Administration
[US] Substance Abuse and Mental Health Services Administration, 2018
Expanding access to medication is an important public health strategy for tackling opioid use disorder, concludes US government agency guidelines. While some people stop using opioids without medication, many benefit from access to methadone, naltrexone, and buprenorphine for varying lengths of time, including lifelong treatment.

STUDY 2018 HTM file
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom

Hickman M., Steer C., Tilling K. et al.
Addiction: 2018, 113(8), p. 1461–1476.
Buprenorphine may be associated with a lower risk of mortality than methadone among people engaged in opioid substitution treatment – but is the pattern of short treatment duration in the UK preventing maximal impact at a population level?

MATRIX CELL 2018 HTM file
Drug Treatment Matrix cell B5: Practitioners; Safeguarding the community

Ashton M.
Key studies on the contribution of the practitioner to reducing crime and safeguarding the community. Risks formulating a general rule: The trickier the situation, the more the worker matters – suggesting that therapeutic skills are even more important in formally coerced than other forms of treatment. Also asks whether those skills can most effectively be deployed when therapy is divorced from criminal justice supervision.

MATRIX CELL 2018 HTM file
Drug Treatment Matrix cell A5: Interventions; Safeguarding the community

Ashton M.
Seminal and key studies shedding light on treatment’s contribution to safeguarding the community and preventing crime. Commentary addresses two highly controversial issues, asking, “Can it ever be safe to leave children with seriously problematic drug users?”, and examining the ethical considerations and evidence on pressuring opioid-dependent offenders to take the opiate-blocker naltrexone.

HOT TOPIC 2018 HTM file
Opiate-blocking implants: magic bullet or dangerous experiment?

Ashton M.
‘Hot topics’ offer background and analysis on important issues which sometimes generate heated debate. Opinion is sharply divided on the ethics and effectiveness of long-acting implanted or injected opiate-blocking medications, products not approved for medical practice in the UK, but which some see as a major breakthroughs in overcoming addiction to heroin and allied drugs.

HOT TOPIC 2018 HTM file
Ethics and evidence on naltrexone treatment of offenders

Ashton M.
‘Hot topics’ offer background and analysis on important issues which sometimes generate heated debate. Opinion is sharply divided on the ethics and effectiveness of pressuring opioid-dependent offenders to take the opiate-blocker naltrexone. Especially sharp is the controversy over long-acting products not approved for medical practice in the UK. Do they constitute an unacceptable infringement of autonomy, or is forcing them on some offenders as caring as holding back someone about to (by choice or not) walk off a cliff?


Select search results page

NEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75